These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8358067)

  • 1. Enhancement of LAK-like activity and cytokine induction in regional lymph nodes and spleen cells of mice after intralymphnodal injection of OK-432, a killed streptococcal preparation.
    Sakakura C; Takahashi T; Hagiwara A; Yamane T; Sawai S; Okano S; Ozaki K; Sasaki S; Tsujimoto H
    Anticancer Drugs; 1993 Jun; 4(3):381-8. PubMed ID: 8358067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of LAK-like cells in the regional lymph nodes and spleen by intralymph-nodal injection of OK-432: preliminary report].
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Yamane T; Okano S; Tsujimoto H
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1506. PubMed ID: 1287465
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective in vivo induction of lymphokine-activated killer (LAK) cells by pretreatment with a streptococcal preparation, OK-432.
    Shimoda K; Saito T; Kobayashi M; Nomoto K
    Biotherapy; 1992; 5(1):63-9. PubMed ID: 1389903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
    Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
    J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
    Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
    Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors.
    Fujioka T; Ishikura K; Tanji S; Okamoto T; Koike H; Aoki H; Ohhori T; Kubo T
    Int J Immunopharmacol; 1990; 12(4):419-26. PubMed ID: 2391188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined effect of intraperitoneally administered OK-432 and recombinant interleukin (rIL-2) against mouse tumors].
    Fujioka T; Shiraishi M; Tanji S; Koike H; Kumagai K; Kubo T; Ohhori T
    Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):948-56. PubMed ID: 2789265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced generation of OK-432-induced killer cells by interleukin 2.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients.
    Takahashi K; Harauchi D; Kimura S; Saito S; Monden Y
    Int J Immunopharmacol; 1998 Aug; 20(8):375-88. PubMed ID: 9778099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer (NK) cell activity in mice with acute graft-versus-host reactions: characterization of a Thy-1+ NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes.
    MacDonald GC; Gartner JG
    Scand J Immunol; 1991 May; 33(5):553-65. PubMed ID: 1709518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432.
    Okamoto M; Kaji R; Kasetani H; Yoshida H; Moriya Y; Saito M; Sato M
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):232-42. PubMed ID: 8334107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of NKR-P1 is not an absolute requirement for natural killer activity in BDIX rats.
    Pinard D; Olsson NO; Chambers WH; Martin F
    Cancer Immunol Immunother; 1996 Jan; 42(1):15-23. PubMed ID: 8625362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct antitumor mechanisms of recombinant interleukin-2 on recombinant interleukin-2-activated killer-sensitive and -resistant murine tumors.
    Maekawa R; Kitagawa T; Koizumi K; Sato K; Homma M
    J Biol Response Mod; 1989 Dec; 8(6):676-90. PubMed ID: 2600605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans.
    Scaringi L; Cornacchione P; Rosati E; Boccanera M; Cassone A; Bistoni F; Marconi P
    Cell Immunol; 1990 Sep; 129(2):271-87. PubMed ID: 2166624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer cells and aging in mice: significance for defining the precursor cell.
    Kawakami K; Bloom ET
    Mech Ageing Dev; 1987 Dec; 41(3):229-40. PubMed ID: 2892985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.